Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stenzl

Showing results (791-800 of 819) with videos related to

Pageof 82
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2016
Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1Matthew Smith, Johann De Bono, Cora Sternberg, et al.
JAMA Oncology|February 10, 2022
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical TrialNicholas J Vogelzang, Tomasz M Beer, Winald Gerritsen, et al.
European Urology|August 3, 2012
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assayJens Hansen, Marco Auprich, Sascha A Ahyai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2017
Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell CarcinomaRobert J Motzer, Naomi B Haas, Frede Donskov, et al.
European Urology Focus|January 6, 2021
Definition of a Structured Training Curriculum for Robot-assisted Radical Cystectomy with Intracorporeal Ileal Conduit in Male Patients: A Delphi Consensus Study Led by the ERUS Educational BoardPaolo Dell'Oglio, Filippo Turri, Alessandro Larcher, et al.
European Urology|May 22, 2023
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary FacultyAristotelis Bamias, Arnulf Stenzl, Stephanie L Brown, et al.
World Journal of Urology|February 21, 2020
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
BJU International|February 4, 2015
Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspectivesThorsten Bach, Rolf Muschter, Thomas R W Herrmann, et al.
World Journal of Urology|February 16, 2015
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
BJU International|December 20, 2021
Nomograms including the UBC<sup>®</sup> Rapid test to detect primary bladder cancer based on a multicentre datasetChristina J Meisl, Pierre I Karakiewicz, Roland Einarsson, et al.
Pageof 82

Showing results (791-800 of 819) with videos related to

Sort By:
Pageof 82
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2016
Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1Matthew Smith, Johann De Bono, Cora Sternberg, et al.
JAMA Oncology|February 10, 2022
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical TrialNicholas J Vogelzang, Tomasz M Beer, Winald Gerritsen, et al.
European Urology|August 3, 2012
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assayJens Hansen, Marco Auprich, Sascha A Ahyai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2017
Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell CarcinomaRobert J Motzer, Naomi B Haas, Frede Donskov, et al.
European Urology Focus|January 6, 2021
Definition of a Structured Training Curriculum for Robot-assisted Radical Cystectomy with Intracorporeal Ileal Conduit in Male Patients: A Delphi Consensus Study Led by the ERUS Educational BoardPaolo Dell'Oglio, Filippo Turri, Alessandro Larcher, et al.
European Urology|May 22, 2023
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary FacultyAristotelis Bamias, Arnulf Stenzl, Stephanie L Brown, et al.
World Journal of Urology|February 21, 2020
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
BJU International|February 4, 2015
Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspectivesThorsten Bach, Rolf Muschter, Thomas R W Herrmann, et al.
World Journal of Urology|February 16, 2015
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
BJU International|December 20, 2021
Nomograms including the UBC<sup>®</sup> Rapid test to detect primary bladder cancer based on a multicentre datasetChristina J Meisl, Pierre I Karakiewicz, Roland Einarsson, et al.
Pageof 82